|
 |
|
|||||||
|
|||||||||
© 2005 by the American Diabetes Association, Inc.
Clinical Care/Education/Nutrition |
Sex Disparities in Treatment of Cardiac Risk Factors in Patients With Type 2 Diabetes
1 Diabetes Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
2 General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
Address correspondence and reprint requests to Deborah J. Wexler, MD, MSc, Diabetes Unit, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114. E-mail: dwexler{at}partners.org
OBJECTIVE—Diabetes eliminates the protective effect of female sex on the risk of coronary heart disease (CHD). We assessed sex differences in the treatment of CHD risk factors among patients with diabetes.
RESEARCH DESIGN AND METHODS—A cross-sectional analysis included 3,849 patients with diabetes treated in five academic internal medicine practices from 2000 to 2003. Outcomes were stratified by the presence of CHD and included adjusted odds ratios (AORs) that women (relative to men) were treated with hypoglycemic, antihypertensive, lipid-lowering medications or aspirin (if indicated) and AORs of reaching target HbA1c, blood pressure, or lipid levels.
RESULTS—Women were less likely than men to have HbA1c <7% (without CHD: AOR 0.84 [95% CI 0.75–0.95], P = 0.005; with CHD: 0.63 [0.53–0.75], P < 0.0001). Women without CHD were less likely than men to be treated with lipid-lowering medication (0.82 [0.71–0.96], P = 0.01) or, when treated, to have LDL cholesterol levels <100 mg/dl (0.75 [0.62–0.93], P = 0.004) and were less likely than men to be prescribed aspirin (0.63 [0.55–0.72], P < 0.0001). Women with diabetes and CHD were less likely than men to be prescribed aspirin (0.70 [0.60–0.83], P < 0.0001) or, when treated for hypertension or hyperlipidemia, were less likely to have blood pressure levels <130/80 mmHg (0.75 [0.69–0.82], P < 0.0001) or LDL cholesterol levels <100 mg/dl (0.80 [0.68–0.94], P = 0.006).
CONCLUSIONS—Women with diabetes received less treatment for many modifiable CHD risk factors than diabetic men. More aggressive treatment of CHD risk factors in this population offers a specific target for improvement in diabetes care.
Abbreviations: ADA, American Diabetes Association • AOR, adjusted odds ratio • ARB, angiotensin receptor blocker • CHD, coronary heart disease • NCQA, National Committee on Quality Assurance
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Find additional patient-related information at:
This article has been cited by other articles:
|
|
 |
|
  I. Gouni-Berthold, H. K. Berthold, C. S. Mantzoros, M. Bohm, and W. Krone Sex Disparities in the Treatment and Control of Cardiovascular Risk Factors in Type 2 Diabetes Diabetes Care, July 1, 2008; 31(7): 1389 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Keyhani, J. V. Scobie, P. L. Hebert, and M. A. McLaughlin Gender Disparities in Blood Pressure Control and Cardiovascular Care in a National Sample of Ambulatory Care Visits Hypertension, April 1, 2008; 51(4): 1149 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF]
|
|
|
|
|
|
A. Ferrara, C. M. Mangione, C. Kim, D. G. Marrero, D. Curb, M. Stevens, J. V. Selby, and for the Translating Research Into Action for Diabe Sex Disparities in Control and Treatment of Modifiable Cardiovascular Disease Risk Factors Among Patients With Diabetes: Translating Research Into Action for Diabetes (TRIAD) Study Diabetes Care, January 1, 2008; 31(1): 69 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sirois, J. Moisan, P. Poirier, and J.-P. Gregoire Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes Diabetes Care, July 1, 2007; 30(7): 1880 - 1882. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pilote, K. Dasgupta, V. Guru, K. H. Humphries, J. McGrath, C. Norris, D. Rabi, J. Tremblay, A. Alamian, T. Barnett, et al. A comprehensive view of sex-specific issues related to cardiovascular disease Can. Med. Assoc. J., March 13, 2007; 176(6): S1 - S44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Grant and J. B. Meigs Prevalence and Treatment of Low HDL Cholesterol Among Primary Care Patients With Type 2 Diabetes: An unmet challenge for cardiovascular risk reduction Diabetes Care, March 1, 2007; 30(3): 479 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 6, 2007; 115(5): e69 - e171. [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Weiss, D. C. Henderson, J. B. Weilburg, D. C. Goff, J. B. Meigs, E. Cagliero, and R. W. Grant Treatment of Cardiac Risk Factors Among Patients With Schizophrenia and Diabetes Psychiatr Serv, August 1, 2006; 57(8): 1145 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Huxley, F. Barzi, and M. Woodward Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies BMJ, January 14, 2006; 332(7533): 73 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Marks Heart Disease and Women: Is the Right Message Getting Through? Clin. Diabetes, October 1, 2005; 23(4): 147 - 149. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |